Lin Patrick (CIK 1799363) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy PCSA (2,106 shares), Buy PCSA (1,831 shares), Buy PCSA (1,582 shares), Buy PCSA (1,369 shares), Buy PCSA (1,511 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business - Strategy Off | Buy | 2,106 | $4,065 |
| 2026-06-16 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business - Strategy Off | Buy | 1,831 | $4,065 |
| 2026-06-01 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business - Strategy Off | Buy | 1,582 | $4,066 |
| 2026-05-19 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business - Strategy Off | Buy | 1,369 | $4,066 |
| 2026-05-01 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business - Strategy Off | Buy | 1,511 | $4,065 |
| 2026-04-17 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business - Strategy Off | Buy | 1,369 | $4,066 |
| 2026-02-04 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business - Strategy Off | Buy | 193 | $0 |
| 2025-04-11 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business - Strategy Off | Buy | 14,482 | $0 |
| 2025-04-11 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business - Strategy Off | Sell | 4,814 | $1,974 |
| 2025-01-29 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Business - Strategy Off | Buy | 43,500 | $0 |
Source: SEC Form 4 filings · as of 2026-07-01